Jo Harnaha

1.3k total citations
25 papers, 1.1k citations indexed

About

Jo Harnaha is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Jo Harnaha has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Jo Harnaha's work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (8 papers). Jo Harnaha is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (8 papers). Jo Harnaha collaborates with scholars based in United States, Italy and Germany. Jo Harnaha's co-authors include Nick Giannoukakis, Massimo Trucco, Brett E. Phillips, David N. Finegold, Robert Lakomy, Alexis Styche, Massimo Trucco, John J. Fung, Shiguang Qian and Angus W. Thomson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jo Harnaha

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo Harnaha United States 13 816 255 251 154 103 25 1.1k
José Luis Vela United States 18 611 0.7× 90 0.4× 312 1.2× 130 0.8× 39 0.4× 27 955
E K Gao United States 11 868 1.1× 145 0.6× 205 0.8× 113 0.7× 31 0.3× 13 1.2k
Guillermo Arreaza Canada 18 1.0k 1.3× 678 2.7× 166 0.7× 344 2.2× 234 2.3× 35 1.5k
Marynette Rihanek United States 12 459 0.6× 180 0.7× 403 1.6× 113 0.7× 103 1.0× 16 1.0k
S Ono Japan 15 748 0.9× 85 0.3× 198 0.8× 78 0.5× 28 0.3× 27 1.2k
Kazuhiro Hayashida Japan 17 725 0.9× 101 0.4× 367 1.5× 79 0.5× 40 0.4× 44 1.4k
Dolca Thomas United States 10 1.0k 1.3× 101 0.4× 208 0.8× 142 0.9× 37 0.4× 13 1.4k
Deborah D. Glass United States 18 1.3k 1.6× 130 0.5× 172 0.7× 95 0.6× 25 0.2× 22 1.6k
Uri Nir Israel 10 404 0.5× 159 0.6× 358 1.4× 71 0.5× 24 0.2× 13 826
Eugene S. Medlock United States 13 487 0.6× 90 0.4× 302 1.2× 109 0.7× 18 0.2× 25 878

Countries citing papers authored by Jo Harnaha

Since Specialization
Citations

This map shows the geographic impact of Jo Harnaha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Harnaha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Harnaha more than expected).

Fields of papers citing papers by Jo Harnaha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Harnaha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Harnaha. The network helps show where Jo Harnaha may publish in the future.

Co-authorship network of co-authors of Jo Harnaha

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Harnaha. A scholar is included among the top collaborators of Jo Harnaha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Harnaha. Jo Harnaha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Brett E., et al.. (2014). Involvement of Suppressive B-Lymphocytes in the Mechanism of Tolerogenic Dendritic Cell Reversal of Type 1 Diabetes in NOD Mice. PLoS ONE. 9(1). e83575–e83575. 43 indexed citations
2.
D’Anneo, Antonella, et al.. (2011). Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity. Immunologic Research. 50(2-3). 130–152. 5 indexed citations
3.
Giannoukakis, Nick, Brett E. Phillips, David N. Finegold, Jo Harnaha, & Massimo Trucco. (2011). Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients. Diabetes Care. 34(9). 2026–2032. 329 indexed citations
4.
Phillips, Brett E., Karen D. Nylander, Jo Harnaha, et al.. (2008). A Microsphere-Based Vaccine Prevents and Reverses New-Onset Autoimmune Diabetes. Diabetes. 57(6). 1544–1555. 74 indexed citations
6.
Harnaha, Jo, et al.. (2006). Interleukin-7 Is a Survival Factor for CD4+ CD25+ T-Cells and Is Expressed by Diabetes-Suppressive Dendritic Cells. Diabetes. 55(1). 158–170. 74 indexed citations
7.
Corcoran, David L., Eleanor Feingold, Jo Harnaha, et al.. (2005). Footer: A quantitative comparative genomics method for efficient recognition ofcis-regulatory elements. Genome Research. 15(6). 840–847. 20 indexed citations
8.
Tiao, Mao‐Meng, Liwei Lu, Ran Tao, et al.. (2004). Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness. Transplantation Proceedings. 36(5). 1592–1594. 8 indexed citations
9.
Harnaha, Jo, et al.. (2004). Antisense Oligonucleotides Down-Regulating Costimulation Confer Diabetes-Preventive Properties to Nonobese Diabetic Mouse Dendritic Cells. The Journal of Immunology. 173(7). 4331–4341. 134 indexed citations
10.
Ma, Linlin, William A. Rudert, Jo Harnaha, et al.. (2002). Immunosuppressive Effects of Glucosamine. Journal of Biological Chemistry. 277(42). 39343–39349. 88 indexed citations
11.
Beckebaum, Susanne, Vito R. Cicinnati, Grzegorz Dworacki, et al.. (2002). Reduction in the Circulating pDC1/pDC2 Ratio and Impaired Function of Ex Vivo-Generated DC1 In Chronic Hepatitis B Infection. Clinical Immunology. 104(2). 138–150. 88 indexed citations
12.
Giannoukakis, Nick, Catherine A. Bonham, Shiguang Qian, et al.. (2000). Prolongation of Cardiac Allograft Survival Using Dendritic Cells Treated with NF-κB Decoy Oligodeoxyribonucleotides. Molecular Therapy. 1(5). 430–437. 119 indexed citations
13.
Beckebaum, Susanne, et al.. (2000). Chronic hepatitis B virus infection is associated with impaired function of dendritic cells. Journal of Hepatology. 32. 89–89. 1 indexed citations
14.
Harnaha, Jo, Prakash Rao, John L. Flowers, et al.. (1992). Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin.. PubMed. 24(4). 1403–5. 6 indexed citations
15.
Cramer, Donald V., Shiguang Qian, Jo Harnaha, et al.. (1989). Accelerated graft arteriosclerosis is enhanced by sensitization of the recipient to donor lymphocytes.. PubMed. 21(4). 3714–5. 15 indexed citations
18.
Proctor, J.W., et al.. (1981). Development of a bioassay for the antitumor activity of biological response modifiers of the reticuloendothelial stimulant class. Cancer Immunology Immunotherapy. 10(4). 5 indexed citations
19.
Tolbert, William R., C. P. Eng, Jo Harnaha, & Joseph P. Concannon. (1975). Establishment of heteroploid cell lines from mouse peritoneal exudate cells. In Vitro Cellular & Developmental Biology - Plant. 11(5). 255–263. 1 indexed citations
20.
Eng, C. P., William R. Tolbert, Jo Harnaha, & Joseph P. Concannon. (1974). In vitro measurement of cytotoxic antibodies in mouse-immune sera against mouse ascites tumor cells. Canadian Journal of Microbiology. 20(12). 1681–1688. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026